The Centre on Wednesday Approved Biological E's #Corbevax as a Heterologous Precaution ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, 'The Centre on Wednesday approved Biological E's #Corbevax as a heterologous precaution dose for adults above 18 years for restricted use with two doses of either #Covishield or #Covaxin.'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)